AV-0213W

N/A

Report date: 2025/06/11 11:06:22

Base Information

Drug NameAV-0213W

Drug Alias Namelive attenuated Salmonella typhimurium prophylactic vaccine (YS1646 vector) (Aviex)Cathepsin B inhibitor (live attenuated, YS1646 vector) (Aviex Technologies)AVIEX-AV-0213WAV-0213W

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionCathepsin B inhibitors

TargetsCathepsin B

Therapy Area/IndicationsSchistosomiasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAviex Technologies Llc

China Registration ClassN/A

Develop Information

Active CompaniesAviex Technologies Llc

Inactive CompaniesN/A

Active IndicationsSchistosomiasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A